Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enkephalinase refers to a group of enzymes responsible for the degradation of enkephalins, endogenous opioid peptides acting as neurotransmitters. These enzymes, including Aminopeptidase N, Neutral Endopeptidase (Neprilysin), Enkephalinase A1/A2, and Enkephalinase B, play a crucial role in regulating the physiological effects of enkephalins by controlling their breakdown and duration of action. Inhibition of these enzymes has therapeutic potential for pain management, depression/anxiety disorders, addiction, and gastrointestinal disturbances.
Inhibition of enkephalin degradation, leading to increased enkephalin levels and enhanced opioid receptor activation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enkephalinase.